stockrow
Friday 6 November 2026
Export CPIX’s income statement to Excel — free account
Cumberland Pharmaceuticals Inc.
CPIX Healthcare Drug Manufacturers Specialty & Generic
Cumberland Pharmaceuticals Inc.’s revenue for fiscal 2025 (year ended December 2025) was $44.5 million, up 17.6% from fiscal 2024.
- Revenue
- −98.5%
- EPS
- −480.0%
- Free cash flow
- −82.8%
- Total debt
- 0.00%
Quarter to June 2026, against a year earlier
5.24
0.23
+4.59%
Follow CPIX
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(13.24%) | (12.05%) | (29.74%) | (48.76%) | |
Piotroski F-Score |
6 | 6 | 3 | 4 | |
| (4.67%) | (3.72%) | (10.48%) | (16.70%) | ||
ROIC |
(22.23%) | (9.51%) | (29.02%) | (34.23%) | |
Return on Tangible Assets |
(56.19%) | (488.90%) | 505.19% | 837.82% | |
Average Days of Receivables |
92.23 | 138.92 | 124.12 | 156.65 | |
Free Cash Flow per Share |
0.45 | 0.32 | 0.09 | 0.04 | |
Free Cash Flow |
6.67 | 4.75 | 1.34 | 0.58 | |
Capital Expenditures |
(0.17) | (0.18) | (0.09) | (0.17) | |
| Other line items | |||||
Cash ROIC |
14.42% | 11.52% | 3.56% | 2.75% | |
Accounts Receivable Turnover |
3.80 | 3.11 | 3.39 | 2.63 | |
Accounts Payable Turnover |
0.49 | 0.53 | 0.60 | 0.00 | |
Inventory Turnover |
1.72 | 4.31 | 1.92 | 0.00 | |
Average Days of Payables |
788.59 | 780.91 | 657.03 | 0.00 | |
Days of Inventory on Hand |
167.31 | 1.26 | 216.68 | 0.00 | |
Tax Rate |
(0.01) | 0.01 | 0.01 | 0.01 | |
Research and Development Expense of Revenue |
11.33% | 12.50% | 13.66% | 18.12% | |
Selling, General and Administrative Expense of Revenue |
57.92% | 69.73% | 76.23% | 101.89% | |
Share Based Compensation of Revenue |
0.75% | 0.92% | 1.05% | 1.40% | |
Interest Coverage |
(11.33) | (5.63) | (17.26) | (17.35) | |
Operating CF/Net income |
(2.05) | (1.74) | (0.19) | (0.07) | |
Depreciation/Fixed assets |
15.68 | 15.66 | 18.49 | 16.64 | |
Capex/Depreciation |
(0.04) | (0.04) | (0.02) | (0.04) | |
Revenue per Share |
2.76 | 3.00 | 2.80 | 2.09 | |
Operating CF per Share |
0.46 | 0.33 | 0.10 | 0.05 | |
Capex per Share |
(0.01) | (0.01) | (0.01) | (0.01) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.01 |
Columns are period end dates · fundamentals updated 26 Oct 2026